Total Payments
$141,254
2024 Payments
$28,571
Companies
29
Transactions
126
Payment Breakdown by Category
Consulting$100,374 (71.1%)
Research$25,329 (17.9%)
Other$6,355 (4.5%)
Travel$5,921 (4.2%)
Gifts$2,000 (1.4%)
Food & Beverage$1,263 (0.9%)
Education$11.82 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $100,374 | 51 | 71.1% |
| Unspecified | $25,329 | 8 | 17.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,355 | 4 | 4.5% |
| Travel and Lodging | $5,921 | 25 | 4.2% |
| Gift | $2,000 | 1 | 1.4% |
| Food and Beverage | $1,263 | 36 | 0.9% |
| Education | $11.82 | 1 | 0.0% |
Payments by Type
General
$115,924
118 transactions
Research
$25,329
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $25,043 | 37 | $0 (2021) |
| AMAG Pharmaceuticals, Inc. | $22,354 | 8 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $18,133 | 7 | $0 (2024) |
| Seqirus USA Inc | $14,906 | 8 | $0 (2022) |
| Celgene Corporation | $8,680 | 1 | $0 (2024) |
| Grifols USA, LLC | $7,314 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $6,652 | 1 | $0 (2018) |
| ABBVIE INC. | $6,067 | 4 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $4,000 | 2 | $0 (2024) |
| Roche Diagnostics Corporation | $3,947 | 18 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,571 | 13 | Celgene Corporation ($8,680) |
| 2023 | $21,170 | 15 | Teva Pharmaceuticals USA, Inc. ($7,235) |
| 2022 | $9,399 | 11 | Grifols USA, LLC ($3,075) |
| 2021 | $9,942 | 7 | UCB, Inc. ($3,360) |
| 2020 | $18,338 | 7 | AMAG Pharmaceuticals, Inc. ($12,825) |
| 2019 | $29,531 | 28 | AMAG Pharmaceuticals, Inc. ($9,518) |
| 2018 | $15,913 | 12 | UCB, Inc. ($8,826) |
| 2017 | $8,390 | 33 | UCB, Inc. ($4,094) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $735.00 | General |
| 11/06/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | — | Cash or cash equivalent | $2,000.00 | Research |
| Study: WAKIX (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring • Category: Narcoplepsy | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/08/2024 | Teva Pharmaceuticals USA, Inc. | MODAFINIL (Drug), ARMODAFINIL | — | Cash or cash equivalent | $2,240.00 | Research |
| Study: The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry • Category: Central Nervous System | ||||||
| 06/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Consulting Fee | Cash or cash equivalent | $3,141.67 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $1,012.50 | General |
| 05/20/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 05/20/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $337.50 | General |
| 05/15/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | ARMODAFINIL (Drug), MODAFINIL | — | Cash or cash equivalent | $3,444.00 | Research |
| Study: The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry • Category: Sleep | ||||||
| 05/08/2024 | PFIZER INC. | NURTEC ODT (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: PAIN | ||||||
| 02/26/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 02/13/2024 | Celgene Corporation | — | — | Cash or cash equivalent | $8,680.00 | Research |
| Study: ZEPOSIA (Ozanimod) Pregnancy Registry: A Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring | ||||||
| 12/13/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | — | Cash or cash equivalent | $2,250.00 | Research |
| Study: A PHASE 3B STUDY TO EVALUATE BONE MINERAL DENSITY WITH LONG-TERM USE OF RELUGOLIX COMBINATION TABLET IN WOMEN WITH UTERINE FIBROIDS OR ENDOMETRIOSIS • Category: HORMONE THERAPY | ||||||
| 12/06/2023 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $945.00 | General |
| 11/08/2023 | Harmony Biosciences LLC | WAKIX (Drug) | — | Cash or cash equivalent | $2,000.00 | Research |
| Study: WAKIX (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring • Category: Narcolepsy | ||||||
| 08/17/2023 | Teva Pharmaceuticals USA, Inc. | ARMODAFINIL (Drug) | — | Cash or cash equivalent | $2,195.20 | Research |
| Study: The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry • Category: Sleep | ||||||
| 08/10/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | — | Cash or cash equivalent | $2,520.00 | Research |
| Study: A pregnancy registry assessing pregnancy outcomes in patients treated with Ajovy (fremanezumab) • Category: Central Nervous System | ||||||
| 07/04/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Consulting Fee | Cash or cash equivalent | $2,520.00 | General |
| Category: Central Nervous System | ||||||
| 06/07/2023 | AbbVie Inc. | SKYRIZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2023 | BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | NURTEC ODT (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: PAIN | ||||||
| 02/06/2023 | Grifols USA, LLC | Thrombate III (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,280.00 | General |
| Category: Hematology | ||||||
| 02/06/2023 | Grifols USA, LLC | Thrombate III (Biological) | Travel and Lodging | Cash or cash equivalent | $666.42 | General |
| Category: Hematology | ||||||
| 02/06/2023 | Grifols USA, LLC | Thrombate III (Biological) | Travel and Lodging | Cash or cash equivalent | $143.66 | General |
| Category: Hematology | ||||||
| 02/06/2023 | Grifols USA, LLC | Thrombate III (Biological) | Food and Beverage | In-kind items and services | $100.30 | General |
| Category: Hematology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ZEPOSIA (Ozanimod) Pregnancy Registry: A Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring | Celgene Corporation | $8,680 | 1 |
| The Nuvigil (Armodafinil) Tablets [C-IV]/Provigil (Modafinil) Tablets [C-IV] Pregnancy Registry | Teva Pharmaceuticals USA, Inc. | $7,879 | 3 |
| A pregnancy registry assessing pregnancy outcomes in patients treated with Ajovy (fremanezumab) | Teva Pharmaceuticals USA, Inc. | $2,520 | 1 |
| A PHASE 3B STUDY TO EVALUATE BONE MINERAL DENSITY WITH LONG-TERM USE OF RELUGOLIX COMBINATION TABLET IN WOMEN WITH UTERINE FIBROIDS OR ENDOMETRIOSIS | Sumitomo Pharma America, Inc. | $2,250 | 1 |
| WAKIX (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring | HARMONY BIOSCIENCES LLC | $2,000 | 1 |
| WAKIX (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring | Harmony Biosciences LLC | $2,000 | 1 |
About Dr. Christopher Robinson, MD
Dr. Christopher Robinson, MD is a Obstetrics & Gynecology healthcare provider based in Mount Pleasant, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750353355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Robinson, MD has received a total of $141,254 in payments from pharmaceutical and medical device companies, with $28,571 received in 2024. These payments were reported across 126 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($100,374).
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology, Obstetrics & Gynecology
- Location Mount Pleasant, SC
- Active Since 02/07/2006
- Last Updated 07/12/2019
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1750353355
Products in Payments
- Cimzia (Drug) $21,223
- AJOVY (Biological) $10,254
- FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) (Biological) $7,731
- Thrombate III (Biological) $7,314
- BEXSERO (Biological) $6,652
- NURTEC ODT (Drug) $6,500
- ARMODAFINIL (Drug) $5,639
- SKYRIZI (Biological) $5,092
- WAKIX (Drug) $4,000
- RS Harmony Test Related Products (Device) $3,258
- ORGOVYX (Drug) $2,250
- MODAFINIL (Drug) $2,240
- AFLURIA QUADRIVALENT (Biological) $2,100
- SOLOSEC (Drug) $1,134
- SLYND (Drug) $736.00
- MD Research and Development (Device) $689.38
- DILAPAN-S (Device) $220.36
- CERVIDIL (Drug) $43.80
- JADA SYSTEM (Device) $15.87
- SUPRAX (Drug) $13.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Mount Pleasant
Dr. Michelle Sanders, D.o, D.O
Obstetrics & Gynecology — Payments: $8,918
Obstetrics & Gynecology $8,918
Dr. Jennifer Schmidt, D.o, D.O
Obstetrics & Gynecology — Payments: $4,430
Obstetrics & Gynecology $4,430
Dr. Donna Hemphill, Md, MD
Obstetrics & Gynecology — Payments: $3,048
Obstetrics & Gynecology $3,048
Dr. Michael Swirtz, Md, MD
Obstetrics & Gynecology — Payments: $2,282
Obstetrics & Gynecology $2,282
Dr. Loren Frankel, M.d, M.D
Obstetrics & Gynecology — Payments: $1,872
Obstetrics & Gynecology $1,872
Dr. Christopher Mason, M.d, M.D
Obstetrics & Gynecology — Payments: $1,429
Obstetrics & Gynecology $1,429